Left ventricular assist devices versus medical management in ambulatory heart failure patients: An analysis of INTERMACS Profiles 4 and 5-7 from the ROADMAP Study
The ROADMAP study showed survival with improved functional status was better with left ventricular assist device (LVAD) therapy compared to optimal medical management (OMM) in ambulatory, non-inotrope dependent (INTERMACS [IM] profile 4-7) patients. To study more balanced cohorts and better define which patients may benefit from implantation of an LVAD, we re-evaluated the patients enrolled in ROADMAP stratified by INTERMACS profile (4 and 5-7).
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Keyur B. Shah, Randall C. Starling, Joseph G. Rogers, Douglas A. Horstmanshof, James W. Long, Vigneshwar Kasirajan, Josef Stehlik, Joyce Chuang, David J. Farrar, Jerry D. Estep, ROADMAP Investigators Source Type: research
More News: Cardiology | Heart | Heart Failure | Heart Transplant | Lung Transplant | Study | Transplants